135
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Correlations of Computed Tomography Measurement of Distal Pulmonary Vascular Pruning with Airflow Limitation and Emphysema in COPD Patients

, ORCID Icon, ORCID Icon, , , , , , , ORCID Icon, , , ORCID Icon, , & show all
Pages 2241-2252 | Received 16 Feb 2022, Accepted 28 Aug 2022, Published online: 14 Sep 2022

References

  • Kovacs G, Agusti A, Barberà JA, et al. Pulmonary vascular involvement in chronic obstructive pulmonary disease. is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000–1011. doi:10.1164/rccm.201801-0095PP
  • Peinado VI, Pizarro S, Barberà JA. Pulmonary vascular involvement in COPD. Chest. 2008;134(4):808–814. doi:10.1378/chest.08-0820
  • Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1):1801887. doi:10.1183/13993003.01887-2018
  • Remy-Jardin M, Ryerson CJ, Schiebler ML, et al. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner society. Radiology. 2021;298(3):531–549. doi:10.1148/radiol.2020203108
  • de Perrot M, Gopalan D, Jenkins D, et al. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT. J Heart Lung Transplant. 2021;40(11):1301–1326. doi:10.1016/j.healun.2021.07.020
  • Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol. 2016;69(2):177. doi:10.1016/j.rec.2016.01.002
  • Blanco I, Piccari L, Barberà JA. Pulmonary vasculature in COPD: the silent component. Respirology. 2016;21(6):984–994. doi:10.1111/resp.12772
  • Takayanagi S, Kawata N, Tada Y, et al. Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? Int J Chron Obstruct Pulmon Dis. 2017;12:551–560. doi:10.2147/copd.S121405
  • Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary Hypertension and Computed Tomography Measurement of Small Pulmonary Vessels in Severe Emphysema. Am J Respir Crit Care Med. 2010;181(3):218–225. doi:10.1164/rccm.200908-1189OC
  • Matsuoka S, Washko GR, Dransfield MT, et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol. 2010;17(1):93–99. doi:10.1016/j.acra.2009.07.022
  • Santos S, Peinado VI, Ramírez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002;19(4):632–638. doi:10.1183/09031936.02.00245902
  • Peinado VI, Barbera JA, Ramirez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274(6):L908–L913. doi:10.1152/ajplung.1998.274.6.L908
  • Barberà JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;149(2 Pt 1):423–429. doi:10.1164/ajrccm.149.2.8306040
  • Noma S, Moskowitz GW, Herman PG, Khan A, Rojas KA. Pulmonary scintigraphy in elastase-induced emphysema in pigs. Correlation with high-resolution computed tomography and histology. Invest Radiol. 1992;27(6):429–435. doi:10.1097/00004424-199206000-00006
  • Hale KA, Niewoehner DE, Cosio MG. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis. 1980;122(2):273–278. doi:10.1164/arrd.1980.122.2.273
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Wells JM, Farris RF, Gosdin TA, et al. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study. Lancet Respir Med. 2016;4(8):636–645. doi:10.1016/S2213-2600(16)30105-9
  • Hammond E, Sloan C, Newell JD, et al. Comparison of low- and ultralow-dose computed tomography protocols for quantitative lung and airway assessment. Med Phys. 2017;44(9):4747–4757. doi:10.1002/mp.12436
  • Synn AJ, Zhang C, Washko GR, et al. Cigarette smoke exposure and radiographic pulmonary vascular morphology in the Framingham heart study. Ann Am Thorac Soc. 2019;16(6):698–706. doi:10.1513/AnnalsATS.201811-795OC
  • McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa1106955
  • Kim W-D, Ling SH, Coxson HO, et al. The association between small airway obstruction and emphysema phenotypes in COPD. Chest. 2007;131(5):1372–1378. doi:10.1378/chest.06-2194
  • Synn AJ, Li W, San José Estépar R, et al. Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham heart study. Eur Respir J. 2019;54(3):1900408. doi:10.1183/13993003.00408-2019
  • Vitulo P, Stanziola A, Confalonieri M, et al. Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial. J Heart Lung Transplant. 2017;36(2):166–174. doi:10.1016/j.healun.2016.04.010
  • Rao RS, Singh S, Sharma BB, Agarwal VV, Singh V. Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. Indian J Chest Dis Allied Sci. 2011;53(2):81–85.
  • Valerio G, Bracciale P, Grazia D’Agostino A. Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2009;3(1):15–21. doi:10.1177/1753465808103499
  • Coste F, Dournes G, Dromer C, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 2016;71(9):830–837. doi:10.1136/thoraxjnl-2015-207696